We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice for healthcare professionals on the reclassification of codeine linctus to a prescription-only medicine (POM), following a public consultation.
This consultation asks for views on the case for introduction of a business rates relief for local newspapers in England
First published during the 2015 to 2016 Cameron Conservative government
Use this form if a Form E1 calculator error has been identified in an online HMCTS FormFinder Form E1, and you assert this has materially or significantly affected your order.
The Business Plan covers the period from June 2021 to March 2022.
This is a summary of analysis on the costs and savings to public services from those receiving treatment for opiate dependence.
Trade remedies notices published by the Secretary of State for International Trade relating to the countervailing duty on bus and lorry tyres from China.
The MHRA is asking for views on a proposal to make Nuromol Dual Action Pain Relief 200mg/500mg tablets (ibuprofen/paracetamol) available without prescription in general sales outlets, such a supermarkets.
Systematic reviews and meta-analyses of randomised controlled trials have highlighted a dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors treated with omega-3-acid ethyl ester medicines compared to placebo.
This PAR covers the assessment of the proposal to make Buscopan IBS Relief, Hyoscine Butylbromide 10mg tablets available through general retail outlets.
Do not stop your hypertriglyceridemia treatment without a discussion with your doctor
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).